CNBC Worldwide Exchange
11 Nov 2024
Jay Woods, Chief Global Strategist at Freedom Capital Markets, highlights the strong rally in small-cap stocks and favors the XPI ETF over IBB, citing its momentum in the biotech sector. He sees Trump’s deregulation benefiting healthcare, speeding up drug approvals.
Link to Video: Woods: Now we can focus on what stocks will lead us
Important Notices and Disclosures
The materials provided here are intended solely for informational and educational use. They do not constitute investment advice, a recommendation of any security or strategy, or an offer for any financial product or service by Freedom Capital Markets (FCM) or its affiliates. The information is not from FCM’s research department and should not be considered a research report or used for investment decisions. FCM is not liable for any reliance on these materials and holds no responsibility for updates. Reproduction or distribution without FCM’s consent is prohibited.
Freedom Capital Markets is the Investment Banking and Equity Capital Markets arm of Prime Executons, Inc., an NYSE, FINRA, and SIPC Member Firm.
Copyright © 2024 by Freedom Capital Markets. All rights reserved.